IL-18 is a pro-inflammatory cytokine of the IL-1 family and it induces IL-1, TNF, and IL-6, all of which are endogenous pyrogens. The pyrogenic properties of recombinant IL-18 were studied in a rabbit model of fever. rIL-18 did not cause fever when injected intravenously into rabbits. Furthermore, the ability of rIL-18 to modulate other components of the acute-phase response was assessed. rIL-18 did not induce leukocytosis, or changes of circulating concentrations of lipoproteins and corticosterone in mice. In conclusion, rIL-18 is not able to induce a febrile response in rabbits and does not modulate the acute-phase response in mice.
Okamura H., Tsutsui H., Komatsu T. et al. Cloning of a new cytokine that induces interferon-γ production by T cells. Nature1995; 378: 88—91.
2.
Yoshimoto T. , Takeda K., Tanaka T. et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production . J Immunol1998; 161: 3400—3407.
3.
Puren AJ, Fantuzzi G., Gu Y., Su MS, Dinarello CAInterleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest1998; 101: 711—721.
4.
Olee T., Hashimoto S., Quach J., Lotz M.IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol1999; 162: 1096—1100.
5.
Dinarello CAIL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol1999; 103: 11—24.
Vogels MT, Cantoni L., Carelli M., Sironi M., Ghezzi P., van der Meer JWRole of acute-phase proteins in interleukin-1-induced nonspecific resistance to bacterial infections in mice. Antimicrob Agents Chemother1993; 37: 2527—2533.
8.
Dinarello CABiologic basis for interleukin-1 in disease . Blood1996; 87: 2095—2147.
9.
Dinarello CA , Gatti S., Bartfai T.Fever: links with an ancient receptor. Curr Biol1999; 9: R147—R150.
Dinarello CA , Cannon JG, Wolf SM et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med1986; 163: 1433—1450.
12.
Sweep CG, van der Meer MJ, Hermus AR et al. Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies. Endocrinology1992; 130: 1153—1164.
13.
Gatti S., Beck J., Fantuzzi G., Bartfai T., Dinarello CAEffect of interleukin-18 on mouse core body temperature. Am J Physiol2002; 282: R702—R709.
14.
Kubota T., Fang J., Brown RA, Krueger JMInterleukin-18 promotes sleep in rabbits and rats. Am J Physiol2001; 281: R828—R838.
15.
Li S., Goorha S., Ballou LR, Blatteis CMIntracerebroventricular interleukin-6, macrophage inflammatory protein-1 beta and IL-18: pyrogenic and PGE(2)-mediated?Brain Res2003; 992: 76—84.
16.
Puren AJ, Fantuzzi G., Dinarello CAGene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci USA1999; 96: 2256—2261.
17.
Culhane AC, Hall MD, Rothwell NJ, Luheshi GNCloning of rat brain interleukin-18 cDNA. Mol Psychiatry1998; 3: 362—366.
18.
Reznikov LL , Kim SH, Westcott JY et al. IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma. Proc Natl Acad Sci USA2000; 97: 2174—2179.
19.
Lee JK, Kim SH, Lewis EC, Azam T., Reznikov LL, Dinarello CADifferences in signaling pathways by IL-1β and IL-18. Proc Natl Acad Sci USA2004; 101: 8815—8820.
20.
Vogels MT, Sweep CG, Hermus AR, van der Meer JWInterleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids. Antimicrob Agents Chemother1992; 36: 2785—2789.
